Growth & profitability
- Revenue has grown 0.9% per year over the past 5 years.
- Net income has grown slower than revenue (-9.8% vs 0.9% per year).
- Free cash flow has declined 8.2% per year over the past 5 years.
HCSG Financials Healthcare Services Group Inc
15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $1.8B | $59M | 13.0% | 0.0% | $139M | — | $125M |
| 2024 | $1.7B | $39M | 13.3% | 0.0% | $24M | — | $57M |
| 2023 | $1.7B | $38M | 12.8% | 0.0% | $38M | — | $54M |
| 2022 | $1.7B | $34M | 11.4% | 0.0% | -$13M | — | $26M |
| 2021 | $1.6B | $49M | 14.0% | 0.0% | $31M | — | — |
| 2020 | $1.8B | $99M | 15.2% | 0.0% | $213M | — | — |
| 2019 | $1.8B | $65M | 12.4% | 0.0% | $89M | — | $27M |
| 2018 | $2.0B | $84M | 11.7% | 0.0% | $75M | — | $26M |
| 2017 | $1.9B | $88M | 13.5% | 0.0% | $2M | — | $10M |
| 2016 | — | $77M | — | — | $36M | — | $24M |
| 2015 | — | $58M | — | — | $58M | — | $33M |
| 2014 | — | $22M | — | — | $52M | — | $75M |
| 2013 | — | $47M | — | — | $28M | — | $64M |
| 2012 | — | $44M | — | — | $57M | — | $69M |
| 2011 | — | $38M | — | — | $27M | — | $39M |
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $463M | $26M | 16.4% | 0.0% | $42M | — | $136M |
| Dec '25 | $467M | $31M | 15.4% | 0.0% | $16M | — | $125M |
| Sep '25 | $464M | $43M | 20.8% | 0.0% | $70M | — | $124M |
| Jun '25 | $458M | -$32M | 0.6% | 0.0% | $27M | — | $83M |
| Mar '25 | $448M | $17M | 15.2% | 0.0% | $26M | — | $64M |
| Dec '24 | $438M | $12M | 13.4% | 0.0% | $35M | — | $57M |
| Sep '24 | $428M | $14M | 14.8% | 0.0% | $3M | — | $27M |
| Jun '24 | $426M | -$2M | 9.7% | 0.0% | $15M | — | $26M |
| Mar '24 | $423M | $15M | 15.2% | 0.0% | -$28M | — | $29M |
| Dec '23 | $424M | $24M | 17.6% | 0.0% | $48M | — | $54M |
| Sep '23 | $411M | -$5M | 8.4% | 0.0% | $1M | — | — |
| Jun '23 | $419M | $8M | 12.1% | 0.0% | $6M | — | $29M |
| Mar '23 | $417M | $12M | 13.1% | 0.0% | -$17M | — | $16M |
| Dec '22 | $424M | $16M | 13.4% | 0.0% | $22M | — | $26M |
| Sep '22 | $414M | $322000 | 9.1% | 0.0% | -$11M | — | — |
| Jun '22 | $425M | $7M | 10.7% | 0.0% | $8M | — | — |
| Mar '22 | $427M | $11M | 12.5% | 0.0% | -$32M | — | — |
| Dec '21 | $420M | $2M | 10.3% | 0.0% | $30M | — | — |
| Sep '21 | $416M | $10M | 12.2% | 0.0% | -$25M | — | — |
| Jun '21 | $398M | $10M | 15.5% | 0.0% | $24M | — | — |
Valuation over time
How the market has priced HCSG against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-earnings ratio has fallen from 27.8× (Mar '23) to 27.5× (Jun '26).
- The price-to-sales ratio has risen from 0.6× (Mar '23) to 0.9× (Jun '26).
- The dividend yield has risen from 6.7% (Mar '23) to 8.9% (Dec '23).
P/E
P/S
Dividend yield %
Frequently asked questions
Is HCSG growing its revenue and profit?
Over the past 5 years, Healthcare Services Group Inc's revenue has grown 0.9% per year, and net income declined 9.8% per year. These are computed facts, not advice.
How much debt does HCSG have?
As of FY2025, Healthcare Services Group Inc reported — of total debt against $125M of cash.
What is HCSG's profit margin?
In FY2025, gross margin was 13.0%, operating margin —, and net margin 3.2%.
What is HCSG's P/E ratio?
As of Jun '26, Healthcare Services Group Inc traded at a price-to-earnings ratio of about 27.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.